UPS in Sri Lanka is proud to announce the delivery of the first batch of Pfizer-BioNTech COVID-19 vaccine at Bandaranaike International Airport, in Sri Lanka on the 5th of July 2021, supporting the country’s fight against the pandemic.
UPS’s temperature-controlled delivery fleet is equipped to maintain ultra-cold storage temperature conditions of Pfizer – BioNTech Covid-19 doses to deliver these life-saving vaccines to the government.
Rachid Fergati, UPS Managing director for Middle East and Indian subcontinent elaborates: “UPS is honoured to support Sri Lanka’s national drive against the COVID pandemic, and our teams have been working around the clock to ensure the smooth delivery of these temperature sensitive vaccines. This is an important milestone in the world’s ongoing collective response to the pandemic and UPS is committed to continue delivering what matters to people and communities that need it most. We have the industry-leading expertise and the world-class logistics network to meet the demands of the highly regulated, complex requirements of these pharmaceuticals. We are proud to be a leading force in public-private partnerships to help stamp out this pandemic in Sri Lanka and across the world.”
Staying at the forefront of the COVID-19 fight, UPS has delivered over 400 million COVD-19 vaccines globally so far and is on track to deliver at least 1 billion vaccines by the end of this year.
About UPS:
UPS (NYSE: UPS) is one of the world’s largest package delivery companies with 2020 revenue of $84.6 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. The company’s more than 540,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes a strong and unwavering stance in support of diversity, equality, and inclusion. The company can be found on the Internet at www.ups.com, with more information at www.pressroom.ups.com and www.investors.ups.com.
